一种结合的in silico方法来设计具有增加受体亚型选择性的配体
Adam Zech1, Victoria Most2, Anna Mutti3
1Institute of Medical Physics and Biophysics, University of Leipzig, Leipzig, Germany.
Journal of molecular biology
|February 15, 2025
概括
这项研究开发了一种计算管道,用于设计G蛋白结合受体的亚型选择性配体. 该方法成功增强了卡帕阿片类受体的选择性,验证了其在药物发现方面的潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算化学的计算化学
- 结构生物学 结构生物学
背景情况:
- G蛋白结合受体 (GPCR) 是关键的药物标,但它们的灵活性给计算药物设计带来了挑战.
- 与GPCR相互作用的联体特别难以建模,因为它们的结构灵活性很高.
- 现有的计算方法往往难以有效地在中采样受体-联体相互作用.
研究的目的:
- 开发和验证用于设计GPCRs的亚型选择性配体的计算管道.
- 使用计算方法增强结合亲和力,提高联体的亚型选择性.
- 将管道应用于针对阿片类受体的迪诺芬变体,旨在实现卡帕-阿片类受体选择性.
主要方法:
- 利用微秒分子动力学模拟来获得受体-连接体复合体的起始构造.
- 采用了Rosetta的FlexPepDock用于灵活的接,以及Rosetta的fixbb用于蛋白质设计,以探索序列空间.
- 从模拟中得出的约束来指导配体的灵活对接.
- 将工作流应用于dynorphin及其与阿片类受体家族成员相互作用的变体.
主要成果:
- 成功预测了因多芬变体与阿片类受体的结合亲和力.
- 确定了六种拟议的变体,具有增强的结合性和亚型选择性.
- 实验验证证证实,六种设计变体中的四种显著增加了卡帕阿片类受体的选择性.
- 展示了计算方法设计亚型选择性联体的潜力.
结论:
- 开发的计算管道对于设计GPCRs的亚型选择性配体是有效的.
- 这种方法有望增强卡帕-阿片类受体选择性,并且可以适应其他配体GPCR系统.
- 这项工作为in silico药物设计和优化基于的治疗方法提供了宝贵的工具.
更多相关视频
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
4.9K
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.3K
相关概念视频
Ligand Binding Sites
12.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.7K
Ligand Binding and Linkage
4.7K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.7K
Structure-Activity Relationships and Drug Design
488
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
488
Conserved Binding Sites
4.1K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.1K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
G Protein-coupled Receptors
11.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.1K
